1858.HK
Beijing Chunlizhengda Medical Instruments Co Ltd
Price:  
9.51 
HKD
Volume:  
778,750
China | Health Care Equipment & Supplies

1858.HK WACC - Weighted Average Cost of Capital

The WACC of Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) is 8.7%.

The Cost of Equity of Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) is 8.75%.
The Cost of Debt of Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) is 5%.

RangeSelected
Cost of equity7.4% - 10.1%8.75%
Tax rate13.3% - 13.6%13.45%
Cost of debt5.0% - 5.0%5%
WACC7.4% - 10.0%8.7%
WACC

1858.HK WACC calculation

CategoryLowHigh
Long-term bond rate2.1%2.6%
Equity market risk premium5.8%6.8%
Adjusted beta0.911.02
Additional risk adjustments0.0%0.5%
Cost of equity7.4%10.1%
Tax rate13.3%13.6%
Debt/Equity ratio
00
Cost of debt5.0%5.0%
After-tax WACC7.4%10.0%
Selected WACC8.7%

1858.HK WACC - Detailed calculations of Beta

LowHigh
Unlevered beta1.021.25
Relevered beta0.871.03
Adjusted relevered beta0.911.02

1858.HK's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 1858.HK:

cost_of_equity (8.75%) = risk_free_rate (2.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.91) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.